| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w29180 |
| 来源ID | Working Paper 29180 |
| Testing Fractional doses of COVID-19 Vaccines | |
| Witold Więcek; Amrita Ahuja; Esha Chaudhuri; Michael Kremer; Alexandre Simoes Gomes; Christopher Snyder; Alex Tabarrok; Brandon Joel Tan | |
| 发表日期 | 2021-08-30 |
| 出版年 | 2021 |
| 语种 | 英语 |
| 摘要 | Due to the enormous economic, health, and social costs of the COVID-19 pandemic, there are high expected social returns to investing in parallel in multiple approaches to accelerating vaccination. We argue there are high expected social returns to investigating the scope for lowering the dosage of some COVID-19 vaccines. While existing evidence is not dispositive, available clinical data on the immunogenicity of lower doses combined with evidence of a high correlation between neutralizing antibody response and vaccine efficacy suggests that half- or even quarter-doses of some vaccines could generate high levels of protection, particularly against severe disease and death, while potentially expanding supply by 450 million to 1.55 billion doses per month, based on supply projections for 2021. An epidemiological model suggests that even if fractional doses are less effective than standard doses, vaccinating more people faster could substantially reduce total infections and deaths. The costs of further testing alternative doses are much lower than the expected public health and economic benefits. However, commercial incentives to generate evidence on fractional dosing are weak, suggesting that testing may not occur without public investment. Governments could support either experimental or observational evaluations of fractional dosing, for either primary or booster shots. Discussions with researchers and government officials in multiple countries where vaccines are scarce suggest strong interest in these approaches. |
| 主题 | International Economics ; Globalization and International Relations ; Health, Education, and Welfare ; Health ; Poverty and Wellbeing ; COVID-19 |
| URL | https://www.nber.org/papers/w29180 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/586854 |
| 推荐引用方式 GB/T 7714 | Witold Więcek,Amrita Ahuja,Esha Chaudhuri,et al. Testing Fractional doses of COVID-19 Vaccines. 2021. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w29180.pdf（664KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
